Caladrius Biosciences, Inc.
Records under this name other than the patents Caladrius Biosciences, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 6 patents it holds.
Showing 1 to 7 of 7 · Back to Caladrius Biosciences, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,569,061 | Stem cell growth media and methods of making and using same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,977,096 | Stem cell growth media and methods of making and using same Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,709,403 | Compositions and methods of vascular injury repair Lapsed on the fee record Ended Apr 29, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 29, 2026 | From the USPTO record |
| US 8,637,005 | Compositions and methods of vascular injury repair Lapsed on the fee record Ended Jan 28, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 28, 2026 | From the USPTO record |
| US 8,450,110 | Human neuronal progenitor cells co-expressing nestin and Pax6, and co-expressing NeuN or Tuj1 Lapsed on the fee record Ended May 28, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 28, 2025 | From the USPTO record |
| US 8,425,899 | Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency Lapsed on the fee record Ended Apr 23, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 23, 2025 | From the USPTO record |
| US 8,211,698 | Methods of derivation of neuronal progenitor cells from embryonic stem cells Lapsed on the fee record Ended Jul 3, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jul 3, 2024 | From the USPTO record |